Eight Medical Spas Participate in Nationwide Pioneering Study
Rochester NY, February 13, 2024 – RESILIÉLLETM Cosmetics LLC, a leader in innovative skincare solutions, proudly announces the successful completion of the world’s first 100-person microneedling-plus-exosome trial, conducted at eight renowned medspas across the country. The clinicians participated in the trial in order to analyze what is the most effective amount of RESILIÉLLE Age Zero ExosomeTM topical serum to be applied after facial microneedling.
During the trial, patients who underwent microneedling received a dose of RESILIÉLLE’s Exosomes on their treated skin. The trial results showed that patients experienced faster recovery after the microneedling, with significant reduction in post-treatment skin redness, a matter of hours instead of days. Clinicians also observed improvements in skin texture, firmness, moisture, smoothness, age spots, pores, and radiance. These welcomed results confirmed that RESILIÉLLE’s product delivered unparalleled results for microneedling participants.
What’s more, the study demonstrated a marked increase in participants’ self-esteem, testimony to the transformative impact of RESILIÉLLE’s products on their overall well-being.
To learn more about the trial results, click here https://vimeo.com/showcase/10915325
RESILIÉLLE donated more than $175,000 of Age Zero Exosomes for use in the study. Principal Investigator and Chief Medical Officer Dr. Corine Cicchetti MD led the study. She is the owner of Buffalo Regenerative Medicine and Aesthetics. Although microneedling has been known to improve skin firmness, Dr. Cicchetti was impressed to see that the use of Age Zero RESILIÉLLE Exosomes revitalized skin damaged by hyperpigmentation caused by decades of sun exposure. She called that “astounding.” “Also,” Dr. Cicchetti added, “my patients are thrilled about Age Zero Exosomes significantly reducing the redness downtime caused by microneedling.”
Erin Crowley, RESILIÉLLE’s CEO, explains, “Our 100-participant study is the scientific validation that our product will bring the highest quality Age Zero Exosomes into the beauty market. We expect RESILIÉLLE Age Zero Exosome Serum being the formulation that customers will trust and demand for their skin care.”
What Patients Reported
Several participants and, one 50-year-old in particular, said, “After the first treatment I saw a big improvement in the texture and brightness of my skin. For the first time in my life, I left my house without face makeup.”
A 47-year-old participant noted, “My skin looks more beautiful now than when I was in my twenties.”
A 52-year-old participant reported, “My overall appearance of my skin with makeup and without has me loving my skin. One of my main goals is to be able to not wear makeup and feel comfortable doing so with only just a tinted moisturizer.”
A 41-year-old participant expressed her enthusiasm for this treatment, saying, “I love this treatment, and I’ve seen a noticeable difference in my skin. I look more radiant, younger and well rested, even when I’m not. I needed less makeup since starting this treatment. I received several compliments from friends and family, as well.”
About RESILIÉLLE Cosmetics LLC
RESILIÉLLE Cosmetics LLC is a pioneer in cutting-edge skincare solutions, driven by a commitment to redefine beauty standards through innovative products and scientific excellence. The Age Zero Exosomes are the most tested and highest quality exosomes available.
Serving an increasing number of global markets, RESILIÉLLE has forged exclusive distribution deals in the United Arab Emirates with reputable partners, such as Great Look Medical Inc., as well as Joy Med in Lebanon, and Arab Health Care in Kuwait. This strategic expansion underscores recognition of RESILIÉLLE’s commitment to exosome excellence.
RESILIÉLLE manufactures the world’s largest production of Age Zero Exosomes in an ISO 7 Cleanroom using “low passage” stem cell expansion standards. In that way, the RESILIÉLLE Exosomes maintain their original characteristics and potency. In order to ensure the integrity of their product’s exosome membrane, for example, Age Zero RESILIÉLLE Exosome products are frozen but are never free-dried during manufacture, in contrast to other products sold on the beauty market. This manufacturing process results in the unmatched quality and efficacy of RESILIÉLLE’s premium skincare formulations. Furthermore, the product is independently tested by a US certified CLIA laboratory. Consequently, customers can have confidence in the integrity and safety of Age Zero RESILIÉLLE Exosomes.
RESILIÉLLE CEO Erin Crowley notes: “I am a quality engineer and Lead ISO Auditor at the helm of a cosmetics company. At RESILIÉLLE we are setting new standards in the science and quality manufacturing of premium skin care, and we are here to disrupt a long-standing industry that is in vital need of change.”
RESILIÉLLE is a wholly owned subsidiary of The Crowley Center for Regenerative & Biotherapeutics that is funded, commercialized and launched by Rochester, NY-based AT Venture Center, a majority women-owned and -operated firm https://www.atventurecenter.com/
For more information on these new offerings, please visit https://www.resilielle.com/ or, in the UAE, https://www.greatlookinc.com/en, or Lebanon https://www.instagram.com/joymedcare/